Cayman Chemical Competitors and Similar CompaniesClear all
Cayman Chemical's competitors and similar companies include Molecular Templates, FibroGen, CanSino Biologics and Cerba Research.
 Cayman Chemical Cayman Chemical Company is a manufacturer and supplier of biochemicals, assay kits, antibodies, and recombinant proteins. |  Molecular Templates Molecular Templates (MTEM) is a biopharmaceutical company focused on the discovery and development of differentiated, targeted, biologic therapeutics for cancer. |  FibroGen FibroGen is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics to treat serious unmet medical needs. |  CanSino Biologics CanSino Biologics (康希诺生物股份公司) is a biopharmaceutical company that provides solutions for the prevention and treatment of infectious diseases. |  Cerba Research Cerba Research is a provider of research and development services for the pharmaceutical and medical device sectors. | |
Founding Date | Founding Date 1980 | Founding Date 2009 | Founding Date 1993 | Founding Date 2009 | Founding Date 2018 |
Type | Type Private | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Ann Arbor, US HQ Neratovice, CZ Tallinn, EE State College, US | Locations Austin, US HQ New York, US | Locations San Francisco, US HQ | Locations Tianjin, CN HQ | Locations Gent, BE HQ Kogarah, AU Montpellier, FR Saint Ouen L'aumône, FR Shinjuku City, JP Johannesburg, ZA see more |
Employees | Employees 2725% decrease | Employees 6272% decrease | Employees 53115% increase | Employees 1,10526% decrease | Employees 619 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 3.3 m | Valuation ($) 30.7 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $57.3m (FY, 2023) | Revenue (est.) $6.4m (FY, 2025) | Revenue (est.) ¥1.1b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $556k (FY, 2025) | Cost of goods ¥81.4m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $5.9m (FY, 2025) | Gross profit ¥1.1b (FY, 2025) | Gross profit N/A |
Net income | Net income N/A | Net income ($8.1m) (FY, 2023) | Net income $183.5m (FY, 2025) | Net income ¥27.9m (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 1.5m | Total funding raised $ 89.6m | Total funding raised N/A | Total funding raised $ 76m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Molecular Templates
HQ
Austin, US
Employees
62
Molecular Templates (MTEM) is a biopharmaceutical company focused on the discovery and development of differentiated, targeted, biologic therapeutics for cancer.
View companyFibroGen
HQ
San Francisco, US
Employees
531↑ 15% increase
FibroGen is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics to treat serious unmet medical needs.
View companyCanSino Biologics
HQ
Tianjin, CN
Employees
1,105↓ 26% decrease
CanSino Biologics (康希诺生物股份公司) is a biopharmaceutical company that provides solutions for the prevention and treatment of infectious diseases.
View companyCerba Research
HQ
Gent, BE
Cerba Research is a provider of research and development services for the pharmaceutical and medical device sectors.
View company